|
Variable
|
Total IES-R score
|
t
|
P value
|
|---|
|
No-to-mild symptoms (n = 24)
|
Moderate-to-severe (n = 61)
|
|---|
|
Age
|
Mean ± SD
|
34.5 ± 8.5
|
36.5 ± 9.7
|
−0.89
|
0.375
|
| |
No
|
%
|
No
|
%
|
χ2
| |
|
Gender
|
Female
|
16
|
66.7
|
53
|
86.9
|
4.608
|
0.032
|
|
Male
|
8
|
33.3
|
8
|
13.1
|
|
Marital status
|
Married
|
20
|
83.3
|
55
|
90.2
|
0.77
|
0.379
|
|
Not married
|
4
|
16.7
|
6
|
9.8
|
|
Residence
|
Rural
|
15
|
62.5
|
40
|
65.6
|
0.071
|
0.790
|
|
Urban
|
9
|
37.5
|
21
|
34.4
|
|
Level of education
|
Low to moderate
|
10
|
41.7
|
43
|
70.5
|
6.10
|
0.014
|
|
High
|
14
|
58.3
|
18
|
29.5
|
|
Occupation
|
Skilled
|
21
|
87.5
|
56
|
91.8
|
1.17
|
0.558
|
|
Employee
|
3
|
12.5
|
4
|
6.6
|
|
Unemployed
|
0
|
0.0
|
1
|
1.6
|
|
Hx of psychiatric illnesses
|
Yes
|
3
|
12.5
|
4
|
6.6
|
0.81
|
0.370
|
|
No
|
21
|
87.5
|
57
|
93.4
|
|
Hx of medical illnesses
|
Yes
|
5
|
20.8
|
14
|
23.0
|
0.044
|
0.833
|
|
No
|
19
|
79.2
|
47
|
77.0
|
|
Hx of COVID-19 symptom severity
|
Mild
|
17
|
70.8
|
23
|
37.7
|
7.59
|
0.006
|
|
Moderate to severe
|
7
|
29.2
|
38
|
62.3
|
|
Medications given during COVID-19 infection
|
Antibiotics
|
21
|
95.5
|
53
|
94.6
|
0.02
|
0.884
|
|
Anticoagulants
|
13
|
59.1
|
36
|
64.3
|
0.18
|
0.669
|
|
Antimalarial
|
11
|
50.0
|
26
|
46.4
|
0.08
|
0.776
|
|
Iverizine
|
14
|
63.6
|
39
|
69.6
|
0.26
|
0.609
|
|
Steroids
|
10
|
45.5
|
35
|
44.9
|
1.88
|
0.170
|
| | | | |
MWU
| |
|
Home isolation (days)
|
Mean ± SD
|
12.59 ± 10.30
|
8.56 ± 9.24
|
−0.91
|
0.361
|
|
Hospital isolation (days)
| |
4.70 ± 6.93
|
7.25 ± 9.73
|
−1.04
|
0.298
|
|
HADS scoring
|
|
Depression
| |
4.17 ± 2.97
|
9.72 ± 3.48
|
−1.41
|
0.157
|
|
Anxiety
| |
4.42 ± 2.98
|
9.74 ± 3.64
|
−1.93
|
0.054
|
- Bold text indicates statistical significance where P value < 0.05
